Delivery Order SPE2DB20D3101-SPE2DB24FRQT0
Award Date
7/24/24
Potential Completion Date
8/14/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,138.25 firm fixed-price delivery order is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, with a period of performance through March 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,325.28 delivery order contract is for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a period of performance through October 4, 2023. The contract is a firm fixed-price, non-set-aside award. Amerisourcebergen also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at up to $1,180.20, is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a medical product, and has a completion date of June 26, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This single-award IDC...
This federal contract award, valued at $2,832.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product, with a completion date of July 26, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds two Indefinite Delivery Contracts (IDCs) with the federal government - one with the DLA Troop Support Medical valued up to...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Rhogam Ultra-Filtered Plus Syringes. The contract has a ceiling value of $2,360.40 and an ultimate completion date of August 8, 2024. AmerisourceBergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of RHOGAM ULTRA-FILTERED PLUS SYRS, a pharmaceutical product. The contract is valued at $1,416.24 on a firm fixed price basis and has an ultimate completion date of August 20, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical valued at up to $999,999,999 through December...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corporation's Corporate Office Division. The award is a delivery order valued at $2,360.40 for the supply of Rhogam Ultra-Filtered Plus syrup, a pharmaceutical product. The contract is a firm-fixed price arrangement with a period of performance through July 2, 2024. Amerisourcebergen Drug Corporation is a major supplier of pharmaceutical products and medical supplies to the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,792.36 firm fixed-price delivery order is for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML, a pharmaceutical product. The contract has an ultimate completion date of October 20, 2022 and was awarded on September 28, 2022. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award to AmerisourceBergen Drug Corp is a Delivery Order valued at $4,590.10 for the supply of RHOPHYLAC 300 MCG/2 ML SYRINGE 2ML medical products. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,981.18 firm fixed-price delivery order is for the supply of HYPERRAB 300UNIT/ML 1S, a pharmaceutical product. The contract has an ultimate completion date of February 29, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...